Literature DB >> 15808222

Robotic cloning and Protein Production Platform of the Northeast Structural Genomics Consortium.

Thomas B Acton1, Kristin C Gunsalus, Rong Xiao, Li Chung Ma, James Aramini, Michael C Baran, Yi-Wen Chiang, Teresa Climent, Bonnie Cooper, Natalia G Denissova, Shawn M Douglas, John K Everett, Chi Kent Ho, Daphne Macapagal, Paranji K Rajan, Ritu Shastry, Liang-Yu Shih, G V T Swapna, Michael Wilson, Margaret Wu, Mark Gerstein, Masayori Inouye, John F Hunt, Gaetano T Montelione.   

Abstract

In this chapter we describe the core Protein Production Platform of the Northeast Structural Genomics Consortium (NESG) and outline the strategies used for producing high-quality protein samples using Escherichia coli host vectors. The platform is centered on 6X-His affinity-tagged protein constructs, allowing for a similar purification procedure for most targets, and the implementation of high-throughput parallel methods. In most cases, these affinity-purified proteins are sufficiently homogeneous that a single subsequent gel filtration chromatography step is adequate to produce protein preparations that are greater than 98% pure. Using this platform, over 1000 different proteins have been cloned, expressed, and purified in tens of milligram quantities over the last 36-month period (see Summary Statistics for All Targets, ). Our experience using a hierarchical multiplex expression and purification strategy, also described in this chapter, has allowed us to achieve success in producing not only protein samples but also many three-dimensional structures. As of December 2004, the NESG Consortium has deposited over 145 new protein structures to the Protein Data Bank (PDB); about two-thirds of these protein samples were produced by the NESG Protein Production Facility described here. The methods described here have proven effective in producing quality samples of both eukaryotic and prokaryotic proteins. These improved robotic and?or parallel cloning, expression, protein production, and biophysical screening technologies will be of broad value to the structural biology, functional proteomics, and structural genomics communities.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15808222     DOI: 10.1016/S0076-6879(05)94008-1

Source DB:  PubMed          Journal:  Methods Enzymol        ISSN: 0076-6879            Impact factor:   1.600


  83 in total

1.  Solution NMR structure of the ARID domain of human AT-rich interactive domain-containing protein 3A: a human cancer protein interaction network target.

Authors:  Gaohua Liu; Yuanpeng J Huang; Rong Xiao; Dongyan Wang; Thomas B Acton; Gaetano T Montelione
Journal:  Proteins       Date:  2010-07

2.  Solution NMR structure of the plasmid-encoded fimbriae regulatory protein PefI from Salmonella enterica serovar Typhimurium.

Authors:  James M Aramini; Paolo Rossi; John R Cort; Li-Chung Ma; Rong Xiao; Thomas B Acton; Gaetano T Montelione
Journal:  Proteins       Date:  2011-01

3.  The structure and enzymatic properties of a novel RNase II family enzyme from Deinococcus radiodurans.

Authors:  Brad J Schmier; Jayaraman Seetharaman; Murray P Deutscher; John F Hunt; Arun Malhotra
Journal:  J Mol Biol       Date:  2011-11-23       Impact factor: 5.469

4.  Three-dimensional structure of the weakly associated protein homodimer SeR13 using RDCs and paramagnetic surface mapping.

Authors:  Hsiau-Wei Lee; Greg Wylie; Sonal Bansal; Xu Wang; Adam W Barb; Megan A Macnaughtan; Asli Ertekin; Gaetano T Montelione; James H Prestegard
Journal:  Protein Sci       Date:  2010-09       Impact factor: 6.725

Review 5.  A community resource of experimental data for NMR / X-ray crystal structure pairs.

Authors:  John K Everett; Roberto Tejero; Sarath B K Murthy; Thomas B Acton; James M Aramini; Michael C Baran; Jordi Benach; John R Cort; Alexander Eletsky; Farhad Forouhar; Rongjin Guan; Alexandre P Kuzin; Hsiau-Wei Lee; Gaohua Liu; Rajeswari Mani; Binchen Mao; Jeffrey L Mills; Alexander F Montelione; Kari Pederson; Robert Powers; Theresa Ramelot; Paolo Rossi; Jayaraman Seetharaman; David Snyder; G V T Swapna; Sergey M Vorobiev; Yibing Wu; Rong Xiao; Yunhuang Yang; Cheryl H Arrowsmith; John F Hunt; Michael A Kennedy; James H Prestegard; Thomas Szyperski; Liang Tong; Gaetano T Montelione
Journal:  Protein Sci       Date:  2015-09-22       Impact factor: 6.725

6.  Advances in Nuclear Magnetic Resonance for Drug Discovery.

Authors:  Robert Powers
Journal:  Expert Opin Drug Discov       Date:  2009-10-01       Impact factor: 6.098

7.  Automatic classification and pattern discovery in high-throughput protein crystallization trials.

Authors:  Christian Cumbaa; Igor Jurisica
Journal:  J Struct Funct Genomics       Date:  2005

8.  Understanding the physical properties that control protein crystallization by analysis of large-scale experimental data.

Authors:  W Nicholson Price; Yang Chen; Samuel K Handelman; Helen Neely; Philip Manor; Richard Karlin; Rajesh Nair; Jinfeng Liu; Michael Baran; John Everett; Saichiu N Tong; Farhad Forouhar; Swarup S Swaminathan; Thomas Acton; Rong Xiao; Joseph R Luft; Angela Lauricella; George T DeTitta; Burkhard Rost; Gaetano T Montelione; John F Hunt
Journal:  Nat Biotechnol       Date:  2009-01       Impact factor: 54.908

9.  Solution NMR structure of CD1104B from pathogenic Clostridium difficile reveals a distinct α-helical architecture and provides first structural representative of protein domain family PF14203.

Authors:  Surya V S R K Pulavarti; Alexander Eletsky; Hsiau-Wei Lee; Thomas B Acton; Rong Xiao; John K Everett; James H Prestegard; Gaetano T Montelione; Thomas Szyperski
Journal:  J Struct Funct Genomics       Date:  2013-09-19

10.  Structural elucidation of the Cys-His-Glu-Asn proteolytic relay in the secreted CHAP domain enzyme from the human pathogen Staphylococcus saprophyticus.

Authors:  Paolo Rossi; James M Aramini; Rong Xiao; Chen X Chen; Chioma Nwosu; Leah A Owens; Melissa Maglaqui; Rajesh Nair; Markus Fischer; Thomas B Acton; Barry Honig; Burkhard Rost; Gaetano T Montelione
Journal:  Proteins       Date:  2009-02-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.